Guggenheim Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$757K	Buy	246,706 +63,259	+34%	+$244K	0.01%	1076
2025 Q4	$750K	Buy	183,447 +57,453	+46%	+$285K	0.01%	1080
2025 Q3	$615K	Buy	125,994 +2,934	+2%	+$15.4K	﹤0.01%	1099
2025 Q2	$623K	Sell	123,060 -23,479	-16%	-$115K	0.01%	1070
2025 Q1	$775K	Buy	146,539 +3,482	+2%	+$25.4K	0.01%	990
2024 Q4	$967K	Sell	143,057 -12,173	-8%	-$81.8K	0.01%	935
2024 Q3	$1.02M	Buy	155,230 +31,724	+26%	+$227K	0.01%	1091
2024 Q2	$926K	Buy	123,506 +81,325	+193%	+$709K	0.01%	1161
2024 Q1	$421K	Sell	42,181 -1,592	-4%	-$17.7K	﹤0.01%	1540
2023 Q4	$432K	Sell	43,773 -158	-0.4%	-$1.13K	﹤0.01%	1513
2023 Q3	$336K	Buy	43,931 +27,119	+161%	+$271K	﹤0.01%	1588
2023 Q2	$126K	Buy	+16,812	New	+$118K	﹤0.01%	1819